首页 › 克罗恩病 › 得克萨斯州 › San Antonio
San Antonio TX 克罗恩病临床试验
15项针对 克罗恩病的研究正在 San Antonio及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Southern Star Research Institute /ID# 280822, San Antonio
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
招募中3 期
- Southern Star Research Institute ( Site 0299), San Antonio
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
招募中3 期
- Southern Star Research Institute ( Site 5000), San Antonio
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- Sun Research Institute /ID# 266723, San Antonio
- Southern Star Research Institute /ID# 278124, San Antonio
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
招募中2 期
- Southern Star Research Institute, LLC, San Antonio
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Gastroenterology Research of America, LLC, San Antonio
- Southern Star Research Institute, LLC, San Antonio
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
招募中2/3 期
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
招募中2 期
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
招募中2 期
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
招募中4 期
- Gastroenterology Research of San Antonio, LLC, San Antonio
- Southern Star Research Institute, LLC., San Antonio
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
招募中3 期
- Southern Star Research Institute, LLC, San Antonio
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
招募中2 期
- Southern Star Research Institute, LLC, San Antonio
其他城市的 克罗恩病试验
- New York City, NY35 项研究
- Boston, MA19 项研究
- Miami, FL19 项研究
- Cleveland, OH19 项研究
- St. Louis, MO19 项研究
- Tyler, TX17 项研究
- Houston, TX17 项研究
- Orlando, FL17 项研究
- Atlanta, GA17 项研究
- San Diego, CA15 项研究
- Los Angeles, CA15 项研究
- Colorado Springs, CO13 项研究
San Antonio的其他研究
- 非小细胞肺癌59 项研究
- 乳腺癌47 项研究
- 结直肠癌46 项研究
- 转移性癌症44 项研究
- 癌症（所有类型）41 项研究
- 肥胖症40 项研究
- 2型糖尿病37 项研究
- 超重34 项研究
- 卵巢癌31 项研究
- 胰腺癌31 项研究
- 前列腺癌28 项研究
- 子宫内膜癌27 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。